Generex Biotec…
ProfileJobs

Generex Biotechnology

Suggest Edit
    • Healthcaredrug developmentpharma

    Generex Biotechnology Corporation is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist device.        

    Type
    Public
    HQ
    Burlington, CA
    Size (employees)
    8 (est)
    Website
    generex.com
    Generex Biotechnology is headquartered in Burlington, CA
    Report incorrect company information

    Generex Biotechnology Office Locations

    Generex Biotechnology has an office in Burlington
    Burlington, CA (HQ)
    4145 N Service Rd
    Show all (1)
    Report incorrect company information

    Generex Biotechnology Financials and Metrics

    Generex Biotechnology Revenue

    USD

    Revenue (Q3, 2018)

    		702.2 k

    Net income (Q3, 2018)

    		21.1 m

    EBIT (Q3, 2018)

    		(1.8 m)

    Cash (30-Apr-2018)

    		1.6 m

    EV

    		2.2 m
    USDQ1, 2018Q2, 2018Q3, 2018

    Revenue

    		2.2 k702.2 k702.2 k

    General and administrative expense

    		401.4 k1.1 m1.8 m

    R&D expense

    		237.8 k388.7 k696.1 k

    Operating expense total

    		639.1 k1.5 m2.5 m
    show all
    Annual
    USDFY, 2017

    Cash

    		2.9 m

    Accounts Receivable

    		980

    Inventories

    		11.1 k

    Current Assets

    		2.9 m
    Quarterly
    USDQ1, 2018Q2, 2018Q3, 2018

    Cash

    		2.3 m2 m1.6 m

    Accounts Receivable

    		175 175

    Inventories

    		12 k12 k12 k

    Current Assets

    		2.6 m2.3 m1.7 m
    show all
    Annual
    USDFY, 2017

    Inventories

    		11.1 k

    Accounts Payable

    		10.2 m

    Cash From Operating Activities

    		(1.2 m)

    Cash From Financing Activities

    		4 m
    Quarterly
    USDQ1, 2018Q2, 2018Q3, 2018

    Net Income

    		27.5 m17.7 m21.1 m

    Depreciation and Amortization

    		1.2 k2 k17.5 k

    Inventories

    		(2 k)(2 k)(2 k)

    Accounts Payable

    		318 k211.7 k673.9 k
    show all
    USDY, 2018

    EV/EBIT

    		-1.2 x

    EV/CFO

    		-1.3 x

    Financial Leverage

    		-0.1 x
    Show all financial metrics
    Report incorrect company information

    Competitors

    Akorn
    Healthcare - Public
    Daiichi Sankyo
    Healthcare - Public
    Adamas Pharmaceuticals
    Healthcare - Public
    CASI Pharmaceuticals
    Healthcare - Public
    Compare competitors

    Generex Biotechnology Online and Social Media Presence

    Embed Graph
    Report incorrect company information

    Generex Biotechnology Company Life and Culture

    Report incorrect company information
    Download PDF